Update on Epstein-Barr virus and gastric cancer (Review)
- 28 January 2015
- journal article
- review article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 46 (4), 1421-1434
- https://doi.org/10.3892/ijo.2015.2856
Abstract
Epstein-Barr virus-associated gastric carcinoma (EBVaGC) is a distinct subtype that accounts for nearly 10% of gastric carcinomas. EBVaGC is defined by monoclonal proliferation of carcinoma cells with latent EBV infection, as demonstrated by EBV-encoded small RNA (EBER) in situ hybridization. EBVaGC has characteristic clinicopathological features, including predominance among males, a proximal location in the stomach, lymphoepithelioma-like histology and a favorable prognosis. EBVaGC belongs to latency type I or II, in which EBERs, EBNA-1, BARTs, LMP-2A and BART miRNAs are expressed. Previous studies have shown that some EBV latent genes have oncogenic properties. Recent advances in genome-wide and comprehensive molecular analyses have demonstrated that both genetic and epigenetic changes contribute to EBVaGC carcinogenesis. Genetic changes that are characteristic of EBVaGC include frequent mutations in PIK3CA and ARID1A and amplification of JAK2 and PD-L1/L2. Global CpG island hypermethylation, which induces epigenetic silencing of tumor suppressor genes, is also a unique feature of EBVaGC and is considered to be crucial for its carcinogenesis. Furthermore, post-transcriptional gene expression regulation by cellular and/or EBV-derived microRNAs has attracted considerable attention. These abnormalities result in significant alterations in gene expression related to cell proliferation, apoptosis, migration and immune signaling pathways. In the present review we highlight the latest findings on EBVaGC from clinicopathological and molecular perspectives to provide a better understanding of EBV involvement in gastric carcinogenesis.Keywords
This publication has 100 references indexed in Scilit:
- Infection of Epstein–Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expressionProceedings of the National Academy of Sciences of the United States of America, 2012
- EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latencyThe EMBO Journal, 2012
- Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysisBritish Journal of Cancer, 2011
- The Epstein–Barr Virus BART microRNAs target the pro-apoptotic protein BimVirology, 2011
- Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency*Published by Elsevier BV ,2010
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic LocationGastroenterology, 2009
- The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen speciesProceedings of the National Academy of Sciences of the United States of America, 2009
- An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survivalThe Journal of Experimental Medicine, 2008
- Modulation of LMP1 protein expression by EBV-encoded microRNAsProceedings of the National Academy of Sciences of the United States of America, 2007
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964